Orodispersible Tablets Market, By Drug Class, By Disease Indication, By Age Group, By Distribution Channel, By Geography

Description

Global orodispersible tablets market is estimated to be valued US$ 9.29 billion in 2023. Over the forecast period, global orodispersible tablets market is expected to exhibit a compound annual growth rate (CAGR) of approximately 10.7%. By 2030, the market size is anticipated to reach USD 18.92 billion.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 9.29 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.70%	2030 Value Projection:	US$ 18.92 Bn

Figure 1. Global Orodispersible Tablets Market Share (%), By Region, 2023

Orodispersible tablets (ODTs) are solid unit dosage forms that disintegrate or dissolve rapidly in the mouth without chewing and without the need for water. The demand for this dosage form has been increasing, especially in pediatric and geriatric patient populations who find swallowing conventional tablets difficult or uncomfortable. ODTs are formulated from various excipients including binders and disintegrants. The most common binders are methacrylic acid copolymers that have high internal strength to support the formulation of high dose drugs. These also have the property of water resistance, and are less sensitive to moisture than standard tablet formulations. The most popular disintegrants are mannitol and aspartame. Orodispersible tablets (ODTs) are a specialized dosage form designed to disintegrate rapidly in the oral cavity, often within a matter of seconds, without the need for additional water or chewing. This unique pharmaceutical formulation is primarily intended to improve patient compliance and convenience, particularly for those who have difficulty swallowing traditional solid oral dosage forms like tablets or capsules. ODTs are commonly used to administer medications, including pain relievers, antihistamines, and treatments for various medical conditions, especially when quick onset of action is essential.

Market Dynamics:

Increasing geriatric population across the globe is anticipated to drive growth of the global orodispersible tablets market. Elderly people prefer self-administration of medications for easy accessibility and convenience. Rising focus on healthcare facilities for the elderly also boosts the market growth.

However, increased pricing pressure is projected to hinder growth of the global orodispersible tablets market in the near future.

Key features of the study:

This report provides in-depth analysis of the global orodispersible tablets market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global orodispersible tablets market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global orodispersible tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orodispersible tablets market

Detailed Segmentation:

By Drug Class:
- Analgesics
- Antiemetics
- Antipsychotics
- Anti-inflammatory Drugs
- Sedatives/Hypnotics
- Antihypertensives
- Others
By Disease Indication:
- Pain Management
- Allergy and Respiratory Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Cardiovascular Disorders
- Others
By Age Group:
- Pediatric Patients
- Adult Patients
- Geriatric Patients
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
Company Profiles:
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Novartis International AG
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Pfizer Inc.
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- F. Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Takeda Pharmaceutical Company Limited

Product Code: CMI5745

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Orodispersible Tablets, By Drug Class
- Market Orodispersible Tablets, By Disease Indication
- Market Orodispersible Tablets, By Age Group
- Market Orodispersible Tablets, By Distribution Channel
- Market Orodispersible Tablets, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
- Market Dynamics
Increasing Prevalence of Chronic Diseases
Technological Advancements in Drug Delivery
Enhanced Patient Compliance and Convenience
Growing Focus on Patient-Centered Care
- Restraints
High Development and Manufacturing Costs
Limited Drug Compatibility and Formulation Options
- Opportunities
Increasing Demand for Personalized Medicine
Rising Adoption of Digital Health Solutions
Development of Innovative Taste-Masking Techniques
Focus on Fast-Dissolving Formulations
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Orodispersible Tablets Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Orodispersible Tablets Market, By Drug Class, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Antiemetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Antipsychotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Sedatives/Hypnotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Antihypertensives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Orodispersible Tablets Market, By Disease Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Allergy and Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gastrointestinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Orodispersible Tablets Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023- 2030
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Orodispersible Tablets Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Orodispersible Tablets Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
North Africa
Central Africa
Rest of Middle East & Africa

10. Competitive Landscape

AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline PLC
Novartis International AG
Johnson & Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Pfizer Inc.
Cipla Limited
Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Lupin Pharmaceuticals, Inc.
Torrent Pharmaceuticals Ltd.
F.Hoffmann-La Roche Ltd.
Eisai Co., Ltd.
Takeda Pharmaceutical Company Limited
Analyst Views

11. Section

Research Methodology
About us